Stockreport

Intensity Therapeutics Selected for Oral Podium Presentation in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society (Sarcomas) Meeting [Yahoo! Finance]

Intensity Therapeutics, Inc.  (INTS) 
PDF biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumorally injected cancer therapies intended to kill tumors direct [Read more]